AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-0.20%35.640.8%$766.84m
JNJJohnson & Johnson
0.34%124.270.6%$764.41m
ABBVAbbVie, Inc.
0.60%105.952.1%$720.72m
MRKMerck & Co., Inc.
0.10%59.130.6%$610.36m
BMYBristol-Myers Squibb Company
-0.08%52.701.4%$505.02m
LLYEli Lilly and Company
0.48%82.051.0%$360.75m
AZNAstraZeneca PLC Sponsored ADR
-0.30%36.331.3%$153.42m
NVSNovartis AG Sponsored ADR
-0.10%77.070.2%$134.97m
GSKGlaxoSmithKline plc Sponsored ADR
-0.15%40.040.2%$111.26m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.55%48.720.1%$80.36m
SNYSanofi Sponsored ADR
-0.05%38.870.2%$45.16m
LCILannett Company, Inc.
-0.15%16.1837.9%$12.30m
EPIXESSA Pharma Inc
1.14%3.560.0%$0.20m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.05%1.881.7%$0.11m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.